INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2007

Salba supplementation reduced blood pressure and inflammatory markers in well-controlled type 2 diabetes.

In a randomized crossover trial, 20 adults with type 2 diabetes consumed 37 +/- 4 g/day of Salba or wheat bran for 12 weeks. Compared with wheat bran, Salba reduced systolic blood pressure by 6.3 +/- 4 mmHg (P < 0.001), high-sensitivity C-reactive protein by 40 +/- 1.6% (P = 0.04), and vonWillebrand factor by 21 +/- 0.3% (P = 0.03). Body weight and kidney function remained unchanged.

Study type
Randomized crossover trial
Who was studied
20 adults with type 2 diabetes, Canada
What was measured
cardiovascular risk factors, blood pressure, hs-CRP, and vWF

THE PAPER

Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial.

Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A. Diabetes Care, 2007.

PubMed 17686832 ↗DOI 10.2337/dc07-1144 ↗

Heart & arteriesDiabetes & blood sugarBlood pressure

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.